Home » Authors » Karen Young

Articles by Karen Young

Vasogen CHF Immune Therapy Succeeds In Phase II CHF Study

March 1, 2002

Amgen Ends Deal With Bioject On Needle-Free Delivery Systems

Feb. 28, 2002

Amgen Ends Deal With Bioject On Needle-Free Delivery Systems

Feb. 28, 2002

Paradigm Enters MetaVantage Alliance With VDDI, Fires CEO

Feb. 27, 2002

Paradigm Enters MetaVantage Alliance With VDDI, Fires CEO

Feb. 27, 2002

Confirmant Unveils Protein Atlas Database For Drug Discovery

Feb. 26, 2002

Angiotech Comes Up Short In Phase II Multiple Sclerosis Study

Feb. 26, 2002

Confirmant Unveils Protein Atlas Database For Drug Discovery

Feb. 26, 2002

Angiotech Comes Up Short In Phase II Multiple Sclerosis Study

Feb. 26, 2002

Restoragen Cuts Half Its Staff, Plans To Rework Business Plan

Feb. 25, 2002

Popular Stories

Today's news in brief
BioWorld
MMP inhibitors divulged in Accure Therapeutics patent
BioWorld Science
Accure Therapeutics has reported new oligopeptide derivatives acting as matrix metalloproteinase-2 (MMP-2) and MMP-9 inhibitors. As such, they are described as...
News in brief
BioWorld Asia
BioWorld Asia briefs for April 14, 2026
Selective CBL-B inhibitor with improved safety profile disclosed
BioWorld Science
CBL-B is a RING-type E3 ubiquitin ligase that acts as a negative regulator of T-cell activation, contributing to immune homeostasis by limiting excessive immune...
MSD discloses new HCN1/2 blockers
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has synthesized new indazole derivatives acting as potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 1...